Medical Device Industry News

  • Facing Felony Charges, Medtech CEO Gets Raise

    The CEO of Vascular Solutions has been charged with promoting a medical device for an unsanctioned uses.Nancy CrottiA company under federal indictment for alleged off-label promotion of a product has warned the Securities & Exchange Commission of the potential for a financial disaster. That was after it gave its embattled CEO a raise.

  • St. Jude Trims Earnings Forecast as Its Stock Hits Record High

    The company’s overall sales dipped 1.3% year over year to $1.35 billion. Meanwhile, its stock is ticked up 6.41% on April 22.Qmed StaffSt. Jude Medical Inc. trimmed its financial projections for the rest of the year as a result of currency fluctuations. The company expects adjusted earnings in the range of $3.92 to $3.97 per share—three cents per share lower than its earlier estimates.

  • DNA Evidence Emerges in Medtech Murder Case

    Allison Feldman in an undated photograph released by the Scottsdale police department.

  • Samsung Has a New Mobile Health Partnership

    Partners HealthCare will work with Samsung Electronics on new chronic disease management tools. Chris Newmarker Partners HealthCare (Boston) this week announced a new partnership with Samsung Electronics to develop what it describes as the next generation of personalized digital- and mobile-based health tools.

  • Medtech Funding Still in the Doldrums in Minnesota

    The situation in one of the United States’ great medtech hubs signals just how hard it has been for medical device venture capital funding to return to pre-Great Recession levels. Nancy Crotti

  • Insurance Companies Question Safety of 510(k) Process

    An insurance lobbying group argues that the pathway should be limited to a narrow set of medical devices.Brian Buntz

  • Medtronic Wins EU Approval for Leadless Pacemaker

    The approval comes a year and a half after St. Jude Medical acquired Nanostim and its EU-approved leadless pacemaker.

  • J&J's Medtech Biz Slumps

    The company is faced with the prospect of slimming its medical device division to restore growth.Brian BuntzJohnson & Johnson’s anemic medical device business in the most recent quarter and the strong U.S. dollar have dimmed the company’s outlook for the year. The company’s medical device division had quarterly sales of $6.3 billion—an 11.4% drop compared with a year prior. Part of the drop was a short-term result of selling off of less-profitable medtech assets while the rest came from pricing pressures and an uptick in competition.

  • iPhone Assembler Entering Medtech Market

    After acquiring a stake in a U.S. medical device firm last year, the world’s biggest electronics manufacturer is in now talks with another medtech company.Brian Buntz

  • IBM Inks Deals with Medtech Heavyweights

    It’s a marriage of high tech and medtech as IBM forges Watson-related partnerships with Medtronic, Johnson & Johnson, and Apple. Nancy CrottiIBM will use its Watson artificial intelligence technology to aggregate and securely deliver health information gathered by personal health-tracking devices, connected medical devices, implantables, and other sensors, the company announced.